Targeting PP2A inhibits the growth of triple-negative breast cancer cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting PP2A inhibits the growth of triple-negative breast cancer cells

Published:2020-02-03 Issue:5 Volume:19 Page:592-600
ISSN:1538-4101
Container-title:Cell Cycle
language:en
Short-container-title:Cell Cycle

Author:

Uddin Mohammed Hafiz¹,Pimentel Julio M.¹²,Chatterjee Madhumita¹,Allen Joshu E.³,Zhuang Zhengping⁴,Wu Gen Sheng¹²

Affiliation:

1. Department of Oncology and Pathology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, USA

2. Cancer Biology Program, Wayne State University School of Medicine, Detroit, MI, USA

3. Department of Research and Development, Oncoceutics, Inc, Philadelphia, PA, USA

4. Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA

Publisher

Informa UK Limited

Subject

Cell Biology,Developmental Biology,Molecular Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15384101.2020.1723195

Reference41 articles.

1. Cancer statistics, 2019

2. Molecular portraits of human breast tumours

3. Triple-Negative Breast Cancer

4. Efficacy and Economics of Hormonal Therapies for Advanced Breast Cancer

5. Adjuvant therapy of triple negative breast cancer

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Paradoxical action of PP2A inhibition and its potential for therapeutic sensitization;Journal of Cellular Physiology;2024-08-16

2. Integrated analysis of -omic landscapes in breast cancer subtypes;F1000Research;2024-06-03

3. A small molecule inhibitor of leucine carboxyl methyltransferase-1 inhibits cancer cell survival;Frontiers in Drug Discovery;2024-04-11

4. PP2A as a potential therapeutic target for breast cancer: Current insights and future perspectives;Biomedicine & Pharmacotherapy;2024-04

5. An LC–MS/MS method for simultaneous determination of LB-100 and its active metabolite, endothall, in human plasma;Bioanalysis;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3